Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

TEST:
AmoyDx® PD-L1 Expression Detection Kit

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Amoy Diagnostics

Type:

Other Approval

Related tests:

‹

AmoyDx® HRD Focus Panel (2)

AmoyDx® PIK3CA Five Mutations Detection Kit (2)

AmoyDx Super-ARMS® EGFR Mutation Detection Kit (1)

AmoyDx® Pan Lung Cancer PCR Panel (1)

AmoyDx EGFR 29 Mutations Detection Kit

AmoyDx MET Mutation Detection Kit

AmoyDx® BRAF V600 Mutations Detection Kit

AmoyDx® BRCA Pro Panel

AmoyDx® BRCA1 and BRCA2 Gene Mutation Detection Kit

AmoyDx® C-KIT Mutation Detection Kit

AmoyDx® EML4-ALK Fusion Gene Detection Kit

AmoyDx® Essential NGS Panel

AmoyDx® FGFR2 Break-apart FISH Probe Kit

AmoyDx® HANDLE Classic NGS Panel

AmoyDx® HANDLE HRR NGS Panel

AmoyDx® HER2 Mutation Detection Kit

AmoyDx® HRD Complete Panel

AmoyDx® Human Papillomavirus (HPV) Genotyping Detection Kit

AmoyDx® JAK2 Mutation Detection Kit

AmoyDx® KRAS Mutation Detection Kit

AmoyDx® KRAS/NRAS Mutations Detection Kit

AmoyDx® MSI detection kit

AmoyDx® Master Panel

AmoyDx® NTRK Gene Fusions Detection Kit

AmoyDx® ROS1 Gene Fusions Detection Kit

AmoyDx®HER-2 Gene Amplification Analysis Kit

AmoyDx® HRD Focus Panel (2)

AmoyDx® PIK3CA Five Mutations Detection Kit (2)

AmoyDx Super-ARMS® EGFR Mutation Detection Kit (1)

AmoyDx® Pan Lung Cancer PCR Panel (1)

AmoyDx EGFR 29 Mutations Detection Kit

AmoyDx MET Mutation Detection Kit

AmoyDx® BRAF V600 Mutations Detection Kit

AmoyDx® BRCA Pro Panel

AmoyDx® BRCA1 and BRCA2 Gene Mutation Detection Kit

AmoyDx® C-KIT Mutation Detection Kit

AmoyDx® EML4-ALK Fusion Gene Detection Kit

AmoyDx® Essential NGS Panel

AmoyDx® FGFR2 Break-apart FISH Probe Kit

AmoyDx® HANDLE Classic NGS Panel

AmoyDx® HANDLE HRR NGS Panel

AmoyDx® HER2 Mutation Detection Kit

AmoyDx® HRD Complete Panel

AmoyDx® Human Papillomavirus (HPV) Genotyping Detection Kit

AmoyDx® JAK2 Mutation Detection Kit

AmoyDx® KRAS Mutation Detection Kit

AmoyDx® KRAS/NRAS Mutations Detection Kit

AmoyDx® MSI detection kit

AmoyDx® Master Panel

AmoyDx® NTRK Gene Fusions Detection Kit

AmoyDx® ROS1 Gene Fusions Detection Kit

AmoyDx®HER-2 Gene Amplification Analysis Kit

›

China’s National Medical Products Administration (NMPA) granted Approval to AmoyDx® PD-L1 Expression Detection Kit (IHC) for guiding the first-line treatment of Pembrolizumab in non-small cell lung cancer patients. E1L3N antibody is highly consistent with 22C3 at an overall agreement rate up to 95.87%, and the good efficacy has verified that the product can better identify patients with NSCLC who are suitable for Pembrolizumab monotherapy.

Cancer:

Non Small Cell Lung Cancer

Gene:

PD-L1 (Programmed death ligand 1)

Drug:

Keytruda (pembrolizumab)

Method:

Immunohistochemistry (IHC)